Morgan Stanley initiated coverage of Heartflow (HTFL) with an Equal Weight rating and $35 price target Heartflow is “a unique MedTech asset” as a pure-play AI and software company, but performance has been strong out of the gate with the stock up 60%-plus since the IPO on August 8, the analyst noted. While investor enthusiasm for the stock is “easy to understand,” the firm believes the current valuation captures optimism around the company’s opportunities.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HTFL: